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This meta‑analysis is aimed to investigate the association between the neutrophil‑to‑lymphocyte 
ratio (NLR) and obstructive sleep apnea (OSA). The PubMed, Web of Science, Google Scholar, and 
cochrane Library databases were searched to collect all relevant articles. the pooled standardized 
mean difference (SMD) with a 95% confidence interval (CI) was calculated using the random effects 
model. In addition, subgroup analysis and meta‑regression analysis were performed. Eleven eligible 
articles containing 2,259 patients with OSA were included in this study. Pooled outcomes revealed 
that the NLR was significantly higher in patients with OSA than in controls (SMD 0.62, 95% CI 0.29–
0.94, P = 0.002). In subgroup analyses, differences in the NLR between patients and controls increased 
with worsening OSA grades. Furthermore, meta‑regression analysis showed that differences in mean 
BMI exerted a significant effect on differences in the NLR (P = 0.0003). In summary, our meta‑analysis 
demonstrated that the NLR in OSA patients was significantly higher than that in controls, and the 
difference was larger in patients with severe OSA. These results indicate that the NLR may be a 
reliable marker for detecting systemic inflammation and predicting disease severity in patients with 
oSA.
Obstructive sleep apnea (OSA) is a chronic inflammatory disorder characterized by recurrent episodes of par-
tial or complete upper airway obstruction during  sleep1,2, affecting 3%–9% of the general  population3. OSA is 
a serious health problem associated with cardiovascular diseases, neurological diseases, and various types of 
 mortality2,4–6. Although the precise underlying mechanisms are not fully understood, systemic inflammation has 
been proposed as a key factor in the pathogenesis of cardiovascular complications in OSA  patients7,8. Therefore, 
investigating the inflammation process is crucial for the management of OSA.
Recently, several markers of systemic inflammation that are obtainable from routine blood tests have attracted 
attention because of their wide availability and low cost. Among them, the neutrophil-to-lymphocyte ratio (NLR) 
has been recognized as a reliable measure of systemic inflammation with prognostic value in various chronic 
 diseases9–12, likely because chronic systemic inflammation activates white blood cells during disease progression.
Previous studies have investigated the relationship between the NLR and OSA but with inconsistent and 
controversial  results13–22. Some researchers have observed significantly elevated NLRs in patients with OSA 
compared to control  groups13,16–20,22, whereas others have  not14,15,21. The incongruity of these results might have 
been due to multiple factors, including the study design, statistical power of the study, and genetic heterogeneity 
of the study population. Therefore, we conducted a comprehensive and systematic review and meta-analysis of 
related studies to determine the associations between the NLR and the presence and severity of OSA.
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Methods
Search strategy. We conducted this systematic review in adherence to the guidelines of the Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses23. A systematic search of publications in the Pub-
Med, Web of Science, Google Scholar, and Cochrane Library electronic databases (until March 24, 2019) was 
conducted using the following MeSH terms and keywords: “sleep apnea syndromes”[MeSH], “obstructive sleep 
apnea”, “sleep apnea”, “OSA”, “sleep-disordered breathing”, “sleep disorders”, “neutrophil to lymphocyte ratio”, 
“neutrophil lymphocyte ratio”, “neutrophil-to-lymphocyte ratio”, and “NLR”. Supplementary Table 1 describe the 
full search strategy.
Eligibility criteria, study selection, and quality assessment. The PICOS (Population, Intervention, 
Comparator, Outcome and Study design) approach was utilized to define study eligibility. (1) P: adult patients 
with OSA (defined as apnea–hypopnea index (AHI) of ≥ 5/hour in sleep studies), (2) I: assessment of NLR, (3) 
C: subjects without OSA or patients with OSA after continuous positive airway pressure (CPAP) treatment (4) 
O: the NLR value, (5) S: observational studies including cross-sectional studies, cohort studies, case–control 
studies, or case series. In addition, studies were eligible if they were written in English and full-text publications. 
Abstracts were independently screened for relevance by two investigators. The full text of relevant articles was 
reviewed independently by two authors. The references of the retrieved articles were also searched to identify 
additional studies. Any disagreement between the reviewers was resolved by a third investigator.
The Newcastle–Ottawa scale (NOS) was used to assess the quality of each study based on the following com-
ponents: selection of the cohort, comparability of cohorts on the basis of the design or analysis, how the exposure 
was ascertained, and how the outcomes of interest were  assessed24. Two researchers independently evaluated the 
quality of each study. Disagreement between the researchers was resolved through consensus. Studies achieving 
six or more stars were considered to be of high quality.
Data extraction. The extracted information was as follows: author name, publication year, country, study 
design, age, sex, mean body mass index (BMI), sample number, OSA severity, and NLR. When the data were 
only graphically  represented18, NLR values were extracted from the graph using Adobe Acrobat’s measuring 
tools (Adobe Systems Incorporated, San Francisco, CA, USA).
Statistical analysis. The meta-analysis of enrolled studies was performed using R 3.4.3 version statisti-
cal software (R Core Team (2017). R: A language and environment for statistical computing. R Foundation for 
Statistical Computing, Vienna, Austria. URL https ://www.R-proje ct.org/.). The difference in the NLR between 
the OSA and control groups was assessed using the standardized mean difference (SMD). Heterogeneity across 
the enrolled studies was calculated using the  I2 test, where  I2 > 50% indicated significant heterogeneity between 
studies and prevented reliance on combined study results. In these cases, the random effects model was used to 
generate pooled effects. By contrast, outcomes without a significant level of heterogeneity  (I2 < 50) were analyzed 
using the fixed effects model. Subgroup analysis was performed to evaluate the effects of disease severity, BMI, 
country, and sex. We also conducted meta-regression analysis to identify possible sources of heterogeneity. Dif-
ferences in mean age (years), proportion of male patients (%), and mean BMI were the sources of heterogene-
ity assessed. A funnel plot and Egger test were used to detect publication  bias25. Additionally, the Duval and 
Tweedie trim-and-fill method was used to adjust for missing studies and correct the overall effect size according 
to publication  bias26. Sensitivity analyses were performed to estimate the influence of each study on the overall 
meta-analysis  results27.
Results
Literature search and study characteristics. The database search using the aforementioned keywords 
and search strategies returned 2,405 articles, 36 of which were excluded because of duplication. After the title 
and abstract screening, we excluded 2,353 articles and read the full text of only 16 articles. Finally, 11 articles 
involving 2,259 OSA patients were included in our meta-analysis13–22,28. The process of study selection is pre-
sented in Fig. 1. Among the 11 studies, nine were conducted in Turkey and two were conducted in East Asia 
(Japan and China). The NOS scores of enrolled studies ranged from 6 to 7, and the publication year ranged from 
2015 to 2019. All enrolled studies were case series and hospital-based studies. Eight  articles13–15,17–19,21,22 provided 
data based on OSA severity (mild: 5 ≤ AHI < 15; moderate: 15 ≤ AHI < 30; and severe: 30 ≤ AHI) and one  article20 
provided data based on BMI (normal weight: BMI < 25; overweight: 25 ≤ BMI ≤ 30; and obesity: 30 < BMI). Two 
 studies18,28 provided NLR value before and after CPAP treatment. The characteristics of the enrolled studies are 
summarized in Table 1.
Associations between the NLR and the presence of OSA. Since 10  studies13–22 fully provided NLR 
values of control subjects and patients with OSA, we included those studies for the meta-analysis to investigate 
association between NLR and the presence of OSA. We used the random effects model due to significant hetero-
geneity between the enrolled studies  (I2 = 95%). A significant difference in the NLR was observed between the 
OSA and control groups (SMD = 0.62, 95% confidence interval (CI) = 0.29–0.94, P = 0.002) (Fig. 2).
Subgroup analysis. To identify possible sources of heterogeneity, subgroup analysis was performed accord-
ing to the severity of OSA, BMI, country, and sex. When studies were stratified by disease severity, differences in 
the NLR between patients and controls increased gradually with OSA severity. The NLR in patients with mild, 
moderate, and severe OSA was significantly higher than that in controls by 0.21 (95% CI = − 0.14 to 0.55, P < 0.01), 
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0.41 (95% CI = − 0.20 to 1.02, P < 0.01), and 0.66 (95% CI = − 0.07 to 1.38, P < 0.01), respectively (Fig. 3a). Fur-
thermore, both non-obese (BMI < 30; SMD = 0.23, 95% CI = 0.03–0.43, P < 0.01) and obese patients (BMI ≥ 30; 
SMD =  1.04, 95% CI = 0.41–1.67, P < 0.01) showed significantly higher NLR compared to controls (Fig. 3b). In 
subsequent subgroup analysis according to country, the difference in the NLR between patients and controls was 
not statistically significant in studies from East Asia (SMD = 0.08, 95% CI = − 0.04 to 0.20, P = 0.61), whereas it 
was statistically significant in studies from Turkey (SMD = 0.73, 95% CI = 0.29–1.17, P < 0.01) (Fig. 4a). When 
we analyzed data according to the sex composition of study patient groups, a statistically significant difference 
in the NLR between patients and controls was observed in studies with mixed sex patient groups (SMD = 0.71, 
95% CI = 0.30–1.12, P < 0.01), but not in studies with only male patients (SMD = 0.06, 95% CI = − 0.07 to 0.18, 
P = 0.95) (Fig. 4b). 
Meta‑regression analysis. We conducted a meta-regression analysis to further assess the effect of con-
founding factors on differences in the NLR between OSA patients and controls. The outcome variable was 
the SMD of the NLR, and the covariates included differences in age (years), BMI, and the proportion of male 
patients (%). Only the difference in BMI (P = 0.0003) was found to exert a significant effect on the difference in 
the NLR, whereas differences in age (P = 0.3849) and the proportion of male patients (%) (P = 0.1275) showed no 
significant effect (Supplementary Fig. 1a–c).
publication bias. Visual inspection of funnel plots revealed the existence of asymmetry (Supplementary 
Fig. 2). Egger’s regression test also suggested evidence of publication bias (t = 2.2406, P = 0.0372). However, the 
trim-and-fill method showed that no study required to ensure symmetry and the adjusted SMD was not changed 
(adjusted SMD = 0.62, 95% CI 0.29–0.94, P = 0.002).
Sensitivity analysis. Stability of the results was evaluated through sensitivity analysis. The corresponding 
pooled SMD values were not substantially altered when single studies were sequentially removed, with an effect 
size ranging between 0.46 and 0.66, suggesting that the results of the meta-analysis were stable (Supplementary 
Fig. 3).
The effect of CPAP treatment on NLR. In our primary search results, two  studies18,28 compared NLR 
before and after CPAP treatment. We performed a meta-analysis of those studies to investigate the effect of 
CPAP treatment on NLR. There was no significant difference in NLR before and after treatment with CPAP 
(P = 0.20) (Supplementary Fig. 4).
Figure 1.  Flow diagram of study search and selection.
4
Vol:.(1234567890)
Scientific RepoRtS |        (2020) 10:10862  | https://doi.org/10.1038/s41598-020-67708-w
www.nature.com/scientificreports/
Discussion
Although the association between the NLR and OSA has drawn considerable attention and has been widely inves-
tigated, previous results have been controversial. In the present study, we comprehensively analyzed the results 
of 10 studies through a meta-analysis and found that the NLR value was higher in OSA patients than in control 
subjects. These results indicate that neutrophilic inflammation may play a key role in the pathogenesis of OSA.
In recent years, both local and systemic inflammation as well as changes in immune response have been 
reported in patients with OSA. Previous studies have indicated that intermittent hypoxia selectively activates 
nuclear factor-κB (NF-κB)  pathways29,30. In addition, the levels of several inflammatory markers, including 




NOSn Age (mean ± SD) Sex (M/F) BMI (mean) NLR (mean ± SD)
Kivanca 2018 Turkey RCS Control 52 41 ± 12 35/17 29 1.90 ± 1.03 6
Mild 53 43 ± 10 44/10 29 2 ± 1
Moderate 65 50 ± 11 47/28 31.3 1.8 ± 1
Severe 130 51 ± 11 101/29 34 1.8 ± 0.7
Fana 2019 China RCS Control 135 46.3 ± 12.04 135/0 24.0 1.72 ± 0.74 7
Mild 185 44.9 ± 11.1 185/0 25.4 1.75 ± 0.95
Moderate 171 46.0 ± 11.17 171/0 26.7 1.78 ± 0.67
Severe 596 43.5 ± 10.93 596/0 29.1 1.76 ± 0.82
Korkmaza 2015 Turkey RCS Control 40 43.3 ± 11.14 14/26 29.27 1.80 ± 0.64 6
Mild 27 44.96 ± 9.25 18/9 29.15 1.78 ± 0.57
Moderate 37 47.24 ± 9.12 21/16 31.97 1.57 ± 0.54
Severe 43 49.35 ± 9.79 26/17 32.6 1.61 ± 0.56
Yeniguna 2015 Turkey PCS Control 38 48.08 ± 8.82 20/18 30.54 1.70 ± 0.71 7
Mild 34 46.75 ± 8.06 24/10 33.97 1.69 ± 0.69
Moderate 30 53.64 ± 12.60 14/16 33.53 2.44 ± 1.44
Severe 34 52.94 ± 12.21 18/16 36.15 3.37 ± 1.21
Uygura 2016 Turkey RCS Control 118 50.3 ± 11.7 61/57 29.4 1.81 ± 0.50 7
Mild 57 53.7 ± 10.8 36/21 30.8 2.39 ± 0.60
Moderate 53 51.8 ± 12.1 30/23 31.6 3.34 ± 0.90
Severe 61 54.5 ± 12.7 39/22 32.1 4.18 ± 1.10
Oyamaa 2016 Japan PCS Control 5 50 ± 14.6 2/3 21.9 1.43 ± 0.36 7
Mild 14 61.8 ± 17.3 9/5 22.4 1.66 ± 0.72
Moderate 26 63.8 ± 9.4 18/8 26.3 1.94 ± 0.80
Severe 50 59.3 ± 13.1 43/7 28.7 2.55 ± 1.62
Moderate-severe (pre-CPAP) 29 62.3 ± 9.5 24/5 27.3 1.85 ± 0.71
Moderate-severe (post-CPAP) 29 62.3 ± 9.5 24/5 27.3 1.62 ± 0.58
Sunbul 2015 Turkey RCS Control 65 48.7 ± 10.2 42/23 26.9 1.49 ± 0.48 7
All 130 49.87 ± ND 91/39 34.42 1.87 ± 0.80
Bozkuşb 2018 Turkey RCS Control 42 44.02 ± 11.35 25/17 23.31 1.55 ± 0.16 7
All (normal weight) 36 42 ± 11.24 20/16 23.34 1.59 ± 0.15
All (overweight) 38 43 ± 7.16 21/17 27.82 1.83 ± 0.30
All (obesity) 39 43.69 ± 7.42 25/14 36.29 2.98 ± 0.29
Koseoglua 2015 Turkey RCS Control 48 43.08 ± 8.88 29/19 27.06 2.02 ± 0.85 6
Mild 67 ND ND ND 1.97 ± 1.25
Moderate 61 ND ND ND 1.87 ± 0.66
Severe 108 ND ND ND 1.85 ± 0.64
Günbatara 2015 Turkey RCS Control 26 44.7 ± 10.4 21/5 27.15 1.73 ± 0.68 6
Moderate 22 49.3 ± 10.6 16/6 32.4 1.95 ± 0.90
Severe 63 51.02 ± 11.1 50/13 33.5 2.29 ± 1.40
Özdemir 2019 Turkey PCS Moderate-severe (pre-CPAP) 29 46 ± 10.11 18/11 34.85 1.56 ± 0.47 6
Moderate-severe (post-CPAP) 29 46 ± 10.11 18/11 35.51 1.63 ± 0.58
Table 1.  Characteristics of enrolled studies. OSA obstructive sleep apnea, NOS Newcastle–Ottawa scale, PCS 
prospective case series, RCS retrospective case series, ND not determined, SD standard deviation, BMI body 
mass index, NLR neutrophil-to-lymphocyte ratio, M male, F female. a These articles divided patients into three 
groups according to disease severity (mild: 5 ≤ apnea–hypopnea index (AHI) < 15; moderate: 15 ≤ AHI < 30; 
and severe: 30 ≤ AHI). b This article divided patients into three groups according to body mass index (BMI) 
(normal weight: BMI < 25; overweight: 25 ≤ BMI ≤ 30; and obesity: 30 < BMI).
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C-reactive protein, interleukin-6, and tumor necrosis factor, have been widely recognized as being higher in 
OSA  patients31–33, suggesting that inflammatory activation is critical in the pathogenesis of OSA. CPAP treatment 
significantly reduces elevated inflammatory markers in OSA  patients34. Several studies have also demonstrated 
that systemic inflammation may contribute to a higher risk of cardiovascular diseases in patients with  OSA7,35 
and elevated levels of inflammatory markers are associated with a higher cardiovascular  risk36.
Because neutrophils and lymphocytes play a major role in inflammatory responses through the release of vari-
ous inflammatory mediators, their absolute counts or relative values may reflect the status of systemic inflamma-
tion. NLR is superior to other individual leukocyte parameters (e.g. neutrophil, lymphocyte, and total leukocyte 
counts) in terms of stability, because it is a ratio of two different immune  pathways37,38. Hence, the NLR has been 
proposed as a novel inflammatory marker associated with many chronic diseases, including coronary heart dis-
ease, hypertension, pulmonary thromboembolism, psoriasis, and various  malignancies12,39–41. A previous study 
also reported an association between an elevated NLR and mortality in a group of non-ST-elevation myocardial 
infarction  patients42. Similarly, our meta-analysis demonstrated that the NLR was associated with OSA. However, 
NLR may be influenced by certain factors, including bacterial  infection43 and  medications44,45. Therefore, the 
NLR is a particularly reliable marker in patients without conditions that may affect inflammatory response. The 
mechanism underlying the elevation of the NLR in OSA patients may be related to hypoxia-induced chronic 
inflammation. Neutrophils from patients with moderate and severe OSA demonstrate prolonged survival, which 
is associated with higher NF-κB levels and worse balance of pro-apoptotic and anti-apoptotic  proteins30,46,47. 
In the case of lymphocytes, some researchers have proposed that the decrease in lymphocytes reflects a higher 
degree of physiological  stress48,49.
In subgroup analyses, we found that the difference in the NLR between patients and controls increased gradu-
ally with the severity of OSA. These findings strongly suggest that the NLR may reflect disease severity, and the 
activation of the inflammatory process is linked to the disease activity of OSA. In addition, considering that the 
difference in the NLR between patients and controls was larger in obese patients and the difference in BMI was 
correlated with the NLR in meta-regression analysis, obesity may play a key role in systemic inflammation in OSA 
patients via unknown mechanisms. Furthermore, several investigators reported that the NLR value was higher 
in obese individuals than in control subjects with normal  weight50,51. Therefore, comparison with BMI-matched 
controls is needed to avoid the confounding effect of obesity on NLR. Notably, no statistically significant differ-
ences in the NLR were observed  between patients and controls in studies with only male patients and studies 
from East Asia. Previous studies using a large US national data set reported that females and non-Hispanic black 
were associated with lower  NLR52,53, indicating that gender and ethnicity may affect NLR value. In addition, given 
that racial difference in inflammatory responses has been  proposed54, increase of inflammatory biomarker levels 
in patients with OSA may be different between races. Similarly, differential inflammatory responses between 
male and female subjects might explain the discrepancy in the results among each subgroup according to sex 
Figure 2.  Comparison of the neutrophil-to-lymphocyte ratio between obstructive sleep apnea patients and 
controls. Calculation was based on the random effects model. The results were expressed as the standardized 
mean difference and 95% confidence intervals. OSA, obstructive sleep apnea; SD, standard deviation; SMD, 
standardized mean difference; CI, confidence interval.
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Figure 3.  Subgroup analysis based on disease severity evaluated using the apnea–hypopnea index and body 
mass index. (a) Studies were divided into three subgroups (mild: 5 ≤ apnea–hypopnea index (AHI) < 15; 
moderate: 15 ≤ AHI < 30; and severe: 30 ≤ AHI) according to disease severity. (b) Studies were divided into two 
subgroups (body mass index (BMI) < 30 and BMI ≥ 30) according to the mean BMI of patients. Calculation 
for each subgroup was based on the random effects model. The results were expressed as the standardized 
mean difference and 95% confidence intervals. OSA, obstructive sleep apnea; SD, standard deviation; SMD, 
standardized mean difference; CI, confidence interval; BMI, body mass index.
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Figure 4.  Subgroup analysis based on country and sex composition of study patients. (a) Studies were 
divided into two subgroups (East Asia and Turkey) according to the country in which the research was 
conducted. Calculation for studies from East Asia and Turkey was based on the fixed and random effects 
models, respectively. (b) Studies were divided into two subgroups (male and mixed sex) according to the sex 
composition of the study patients. Calculation for studies with only male patient groups and studies with mixed-
sex patient groups was based on the fixed and random effects models, respectively. The results were expressed 
as the standardized mean difference and 95% confidence intervals. OSA, obstructive sleep apnea; SD, standard 
deviation; SMD, standardized mean difference; CI, confidence interval.
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composition. It has been described that females show a more pronounced response to inflammatory  stimuli55. 
Furthermore, pro-inflammatory cytokine responses and NF-κB activation of mononuclear cells following sleep 
disturbance were more exaggerated in females than in  males56,57. However, concluding a relationship between 
these parameters and the NLR in OSA patients may be premature because the results were derived from few 
studies. Future studies with a large number of patients may be required to obtain more definitive results.
This study had several limitations. First, there might be a referral bias because all the studies enrolled in 
this meta-analysis were hospital-based studies. Population-based studies may provide more accurate informa-
tion on the general population, compared to hospital-based studies. Second, we excluded articles in foreign 
languages, which may have biased the results. Third, the medication status and co-morbidities of OSA patients 
were unknown, which may represent uncontrollable factors in our analysis. Fourth, all enrolled studies were case 
series, which generally have a lower level of evidence than prospective cohort studies. Fifth, a potential bias may 
be derived from the geographical background of included studies. The majority of included studies investigated 
Turkish population. Further studies conducted in other countries are required to validate our results. Despite 
these limitations, this meta-analysis has several considerable strengths. First, we included the largest number 
of studies available. Second, our study was the first to conduct analyses to investigate the effects of potential 
modifiers.
In summary, our meta-analysis demonstrated that the NLR of patients with OSA was significantly higher 
than that of controls. Furthermore, the difference in the NLR between patients and controls gradually increased 
with the severity of OSA. These findings indicate that the NLR may be a reliable marker for detecting systemic 
inflammation and predicting disease activity in patients with OSA.
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